Announcements

The FASTRO designation honor recognizes exceptional service to the field of radiation oncology and cancer care.

DCI molecular biologist Jason Somarelli, PhD, utilizes comparative and evolutionary biology in his cancer research.

J. Michael Cook, PhD, assistant professor in the Department of Immunology and co-leader of the Flow Cytometry Shared Resource has passed away.

Oncology faculty and providers among 2021 Duke Clinical Leadership Program 2021 graduates,
Including winning project team.

Christopher Counter, PhD, Devon Noonan, PhD, MPH, Charles Gersbach, PhD, Fang-Fang Yin, PhD, Sue Jinks-Robertson, Deborah Muoio, PhD, awarded distinguished professorships.

One of the Neil L. Spector Art of Medicine awardees is DCI member Kimberly Johnson, MD, MHS.

The 4th floor of the new South Pavilion at Duke Raleigh Hospital will be utilized primarily for surgical oncology inpatients.

DCI scientist Ehsan Samei, PhD, Professor of Radiology, Physics, Biomedical Engineering, and Electrical and Computer Engineering, is director of the Center for Virtual Imaging Trials.

Urologic surgical oncologist Michael Cookson, MD, MHA, FACS, has been named chief of the Duke Division of Urology. He starts in August.

Shanta Laurie Garvin MHSA, MPA, CRA, has joined DCI as director of Research Development-Clinical Research.

After a one-year hiatus due to the pandemic, the annual DCI Superstar Awards are back. Submit your nominations.

After 32 years with the Duke Cancer Institute family, breast medical oncologist P. Kelly Marcom, MD, retired from clinical practice at the end of May.

DCI member Fang-Fang Yin, PhD (left) has been named the Gustavo S. Montana Professor of Radiation Oncology, effective July 1.

Thomas Stinchcombe, MD, and Carey Anders, MD, will assume new leadership roles as James Abbruzzese, MD, steps down from these roles, effective July 1.

Duke Professor Emeritus Joseph Odell Moore, MD, to be recognized with the Johns Hopkins University School of Medicine’s Distinguished Medical Alumnus Award on May 14.

Renowned DCI neurosurgeon-scientist Peter Fecci, MD, PhD, is one of three SoM faculty members to be inducted this year into ASCI.

Congrats to Lucy Boyce Kennedy, MD & Divya Natesan, MD (right) who each received a Conquer Cancer 2021 ASCO Annual Meeting Merit Award!

With gratitude for Dr. Lisenbee's many years of service, leadership, and dedication to cancer care and research

DCI member Joseph Heitman, MD, PhD, chair of the Department of Molecular Genetics and Microbiology, elected to National Academy of Sciences.

DCI member Sue Jinks-Robertson, PhD, vice-chair, Dept. of Molecular Genetics and Microbiology examines yeast DNA to learn about cancer.

Beloved DCI member Dawn Tranchino Provenzale, MD, a professor of Medicine in the Division of Gastroenterology, has passed away.

Erin Wood, Senior IT Analyst, Duke Cancer Institute Information Systems, honored with a Duke Presidential Award.

Neelima Navuluri, MD, MPH, receives NCCN Foundation Young Investigator Award for her project to improve lung cancer screening among Black Veterans.

Scott Balderson, PA-C, shares why he’s excited for his new role as president of the Association of Physician Assistants in Cardiothoracic and Vascular Surgery.

Neeraj Agrawal, MD, has accepted the role of director of Medical Oncology for Duke Cancer Institute in Wake County, effective March 15.

In the age of Covid, Community Outreach & Engagement at DCI comes of age, team expands with disparities researcher/associate director

The NCCN has published new best practice recommendations for Management of COVID-19 Infection in Patients with Cancer. Related event on March 20.

Beloved Duke Cancer Institute member Dina Randazzo, DO, assistant professor of Neurosurgery and Neurology, has passed away.

DCI, with 130 cancer centers & orgs, signed letter urging Biden admin. & U.S. states to continue prioritizing cancer patients, survivors in COVID-19 vaccine rollout.

Nobel laureate and DCI member Robert Lefkowitz’ first memoir, “A Funny Thing Happened on the Way to Stockholm,” was published this month.

Susan Dent, MD, co-director of the Duke Cardio-Oncology Program, is a leading international expert in the field. She is also associate director of Clinical Research in DCI's Breast Program.

In an open letter, the NCCN, ACS, and major U.S. cancer centers, inc. DCI, urge public to resume cancer screening & treatment during pandemic.

DCI director Michael B. Kastan, MD, PhD, announced a planned reconfiguration of DCI’s NCI-Designated Research Programs and welcomed new research leaders.

Kevin Oeffinger, MD, is guest co-editor of a new book covering colorectal, lung, cervical, prostate, skin cancer, and ovarian cancer screening.

Ken Young, MD, PhD, will assume the role of chief, Hematopathology Division and DCI Blood Cancer Pathology Service, on Jan. 1, 2021.

Duke Radiology, in the Duke SoM, recently launched the Duke Center for Artificial Intelligence in Radiology.

Brent Hanks, MD, PhD, was named associate director of Translational Science for the Melanoma Disease Group this month.

NCI welcomes the Duke BioRepository & Precision Pathology Center as the new site of the Southern Division of the Cooperative Human Tissue Network.

Monica Cfarku RN, MSN, BMTCN, CCM, NE-BC, has been named Assistant Vice President and Chief of Oncology Nursing Services for the Duke Cancer Institute.

NEW FROM DUKE HEALTH: Comprehensive virtual tour of Duke Health facilities, new med student/fellow/resident recruitment resources, and updated SoM facts & figures.

The Duke Cancer Center Durham and Duke Women’s Cancer Care Raleigh boutiques now open by appointment for in-person shopping, self-image consultations.

For a second year, Arif Kamal, MD, MHS, MBA, FAAHPM, FASCO, has been named an ASCO Advocacy Champion.

DCI medical oncologist Robin Hardie-Hood, MD, division chief of Medical Oncology at DRH, named medical director, Duke Cancer Center North Durham.

Duke Cancer Institute welcomes a new medical oncologist specializing in the treatment of breast cancer. He will practice at two of DCI's Wake County locations.

Join us with your “Don’t Ever Give Up!” spirit to ride any distance, any time and any place throughout August.

Duke Cancer Institute continues to ensure that patients have access to the safest and best-quality care possible.

A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at DCI is part of an effective, two-drug strategy for enlisting the immune system to fight tumors.

Radiation oncologist Joseph Kamel Salama, MD, named to the 2020 class of ASTRO Fellows.

From her family to yours: Duke ortho oncology surgeon Julia Visgauss, MD, invites one and all to this year's virtual event, to be held Sept. 12/13.

The Duke University SoM to expand into a newly-leased research center in RTP. Includes DHVI, CIVICS, Dept. of Surgery, Dept. of Medicine, Immunology, Pediatrics.